Year: 2014
Type: review
Abstract: New radiation modalities have made it possible to prolong the survival of individuals with malignant brain tumors, but symptomatic radiation necrosis becomes a serious problem that can negatively affect a patient's quality of life through severe and lifelong effects. Here we review the relevant literature and introduce our original concept of the pathophysiology of brain radiation necrosis following the treatment of brain, head, and neck tumors. Regarding the pathophysiology of radiation necrosis, we introduce two major hypotheses: glial cell damage or vascular damage. For the differential diagnosis of radiation necrosis and tumor recurrence, we focus on the role of positron emission tomography. Finally, in accord with our hypothesis regarding the pathophysiology, we describe the promising effects of the anti-vascular endothelial growth factor antibody bevacizumab on symptomatic radiation necrosis in the brain.
Source: Neurologia medico-chirurgica
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $75
Awards: Synthesis and evaluation of BSH-containing kojic acid (KA-BSH) as a novel agent for boron neutron capture therapy, Overcome of intractable radiation necrosis. Bevacizumab therapy and beyond bevacizumab, Analysis of pathophysiology of brain radiation necrosis and establishment of novel treatment strategy
OpenAlex ID: W2054083830
